Chicago, ILNCT06063538Now EnrollingIRB Ready

Atrial Fibrillation Clinical Trial in Chicago, IL

Access cutting-edge atrial fibrillation treatment through this early phase 1 clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by University of Chicago

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access atrial fibrillation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related atrial fibrillation treatment provided free

Apply for This Chicago Location

Check if you qualify for this atrial fibrillation clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Atrial Fibrillation Study in Chicago

The purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing cardiac arterial bypass grafting (CABG) or valve surgery.

Sponsor: University of Chicago

Who Can Participate

Inclusion Criteria

Subject aged 20-85 years old.
Patients able to provide written informed consent, understand, and be willing to comply with study-related procedures.
Participants who are scheduled to undergo open-chest cardiac surgery via complete median sternotomy. Includes:
Coronary artery bypass graft (CABG) and/or valve repair/replacement procedures (aortic, mitral, or tricuspid)
Isolated ascending aortic aneurysm replacement/repair
Note: Left atrial appendage (LAA) procedures are allowed if CABG and/or valve repair or replacement is the qualifying surgical procedure, but is not a qualifying surgical procedure on its own.
In sinus rhythm at the time of office visit and prior electrocardiogram (EKG) (note: continuous EKG monitoring for 48 hours is not required).

Exclusion Criteria

Subject unable to give voluntary written informed consent, is unlikely to cooperate or is legally incompetent, including subjects who are institutionalized by court or official order, or in a dependency relationship with, testing center or investigator.
Any condition which could interfere with the subject's ability to comply with the study.
Ongoing participation in an interventional clinical study or during the preceding 30 days.
Female subjects who are pregnant, breastfeeding, were pregnant within the last three months, or are planning to become pregnant during the course of the study.
Active skin or deep infection at the site of implantation.
History of chronic wounds or wound-healing disorders.
Known connective tissue diseases (e.g. Ehlers-Danlos syndrome, Epidermolysis bullosa, Marfan syndrome, Osteogenesis imperfecta).
Immune-suppressed subjects, immune-deficiency subjects (properly managed diabetes mellitus is not an exclusion criterion).
Concomitant oral or IV systemic corticosteroid therapy and/or other constant anti-inflammatory therapies.
Patients already receiving amiodarone as a treatment for atrial fibrillation or ventricular arrhythmias.
Disease of the left pleura, previous intervention in the left pleural space, or chest deformity.
Subjects with end-stage chronic-renal disease / dialysis.
STS (Society of Thoracic Surgeons Score) risk score \>5.5% for 30 day mortality.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT06063538) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Atrial Fibrillation Treatment Options in Chicago, IL

If you're searching for atrial fibrillation treatment options in Chicago, IL, this clinical trial (NCT06063538) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all atrial fibrillation clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Chicago, IL

See all atrial fibrillation clinical trials recruiting in Chicago — not just this study.

Browse Atrial Fibrillation Trials in Chicago →

Browse More Trials by Condition

Atrial Fibrillation TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL